Skip to main content

Advertisement

Figure 2 | Journal of Translational Medicine

Figure 2

From: In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients

Figure 2

Proliferation of mesenchymal stem cells from control (MSC-CTRL) and sarcoma (MSC-SAR) patients during in vitro expansion. Cumulative population doubling (CPD) from MSC-CTRL (nā€‰=ā€‰6) and MSC-SAR (nā€‰=ā€‰6) during seven passages. Results are expressed as best-fit linear regression lines (solid lines) with 95% < confidence intervals (dashed lines).

Back to article page